chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Drug exposure during pregnancy
Clinical narrative: Patient is pregnant and had a prenatal diagnosis of a child with a cleft lip.  Patient's estimated due date of Mar 21, 2010.  An ultrasound diagnosing the cleft lip was done around Nov 13, 2010.
Age: 12.0
Sex: F
Vaccine: FLUN3, MNQ, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site urticaria, Pruritus
Clinical narrative: 20-30 minutes after administration, developed 9 cm diameter area of redness/swelling at site of VARIVAX injection with diffuse pruritis and hives - including trunk and extremities.
Age: 12.0
Sex: F
Vaccine: FLUN3, MNQ, VARCEL
Symptoms: Urticaria
Clinical narrative: 20-30 minutes after administration, developed 9 cm diameter area of redness/swelling at site of VARIVAX injection with diffuse pruritis and hives - including trunk and extremities.
Age: 60.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Arthralgia, Injection site pain
Clinical narrative: The patient describe having severe pain in her left shoulder in the injection sight. Severe pain in her knees, hip and elbow 3 days after receiving the vax. Patient was seen by her PCP and orthopedic dr.
Age: 34.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Injection site anaesthesia
Clinical narrative: Client complained that beginning about 12/13/09, that he began having in his right arm, numbness when his arm is at rest. It radiates from the shoulder down the bicep, into the forearm, and ending in the right thumb and pointer finger. He did say he received 2 pokes because the first syringe was not functioning properly. As client is still having numbness.
Age: 86.0
Sex: F
Vaccine: FLU3
Symptoms: Cough
Clinical narrative: Received flu shot. Had a cough the day after - still has cough
Age: 8.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Chest discomfort
Clinical narrative: C/O chest pressure the evening after receiving the vaccine
Age: 38.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Blood product transfusion, CSF protein increased, CSF white blood cell count negative, Eye movement disorder, Muscle twitching
Clinical narrative: Received H1N1 flu vaccine on 12/8/09. On 12/9/09 patient began to c/o visual blurring. On 12/24/09 received seasonal flu vaccine (GSK AFLLA279AA), but did not complain of sx. Followed up with PCP on 1/5/10 c/o continued visual blurring. Was referred to an ophthamologist who reportedly did not any abnormalities. PCP also referred patient to neurologist, seen 1/7/10 at that time had some limitation of ocular muscle movements. Had MRI which was negative. Presented to Hospital on 1/17/09 c/o twitching and sensory changes. Was admitted with dx of r/o GBS Doctor is attending neurologist. Being treated with immunoglobulin.
Age: 38.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Nuclear magnetic resonance imaging normal, Sensory disturbance, Vision blurred
Clinical narrative: Received H1N1 flu vaccine on 12/8/09. On 12/9/09 patient began to c/o visual blurring. On 12/24/09 received seasonal flu vaccine (GSK AFLLA279AA), but did not complain of sx. Followed up with PCP on 1/5/10 c/o continued visual blurring. Was referred to an ophthamologist who reportedly did not any abnormalities. PCP also referred patient to neurologist, seen 1/7/10 at that time had some limitation of ocular muscle movements. Had MRI which was negative. Presented to Hospital on 1/17/09 c/o twitching and sensory changes. Was admitted with dx of r/o GBS Doctor is attending neurologist. Being treated with immunoglobulin.
Age: 25.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Cough, Pyrexia
Clinical narrative: Fever, cough began day after vaccination. Treating with OTC meds
Age: 1.0
Sex: F
Vaccine: FLU(H1N1), HEP, VARCEL
Symptoms: Injection site cellulitis
Clinical narrative: cellulitis rt thigh- site of vaccine
Age: 19.0
Sex: M
Vaccine: FLU(H1N1), FLUN3, HEPA, FLUN3, FLUX(H1N1), HEPA
Symptoms: Abdominal pain upper, Amnesia, Balance disorder, Grand mal convulsion, Vomiting
Clinical narrative: Patient received Flumist, H1N1 vaccine and Hep A vaccine at the same time. The adverse reaction began with stomach pains on Friday evening 1/15; Saturday afternoon 1/16 he had a severe cough, Sunday morning 1/17 he couldn't keep his balance, Monday morning 1/18 severe vomiting, admittance to hospital. While in hospital, he experienced a grand mal seizure. Patient currently has short term memory loss and cannot answer questions about before Friday evening, 1/15 (this information is from text messages to his mother).
Age: 19.0
Sex: M
Vaccine: FLU(H1N1), FLUN3, HEPA, FLUN3, FLUX(H1N1), HEPA
Symptoms: Abdominal pain upper, Amnesia, Balance disorder, Cough, Grand mal convulsion
Clinical narrative: Patient received Flumist, H1N1 vaccine and Hep A vaccine at the same time. The adverse reaction began with stomach pains on Friday evening 1/15; Saturday afternoon 1/16 he had a severe cough, Sunday morning 1/17 he couldn't keep his balance, Monday morning 1/18 severe vomiting, admittance to hospital. While in hospital, he experienced a grand mal seizure. Patient currently has short term memory loss and cannot answer questions about before Friday evening, 1/15 (this information is from text messages to his mother).
Age: 19.0
Sex: M
Vaccine: FLU(H1N1), FLUN3, HEPA, FLUN3, FLUX(H1N1), HEPA
Symptoms: Laboratory test, Vomiting
Clinical narrative: Patient received Flumist, H1N1 vaccine and Hep A vaccine at the same time. The adverse reaction began with stomach pains on Friday evening 1/15; Saturday afternoon 1/16 he had a severe cough, Sunday morning 1/17 he couldn't keep his balance, Monday morning 1/18 severe vomiting, admittance to hospital. While in hospital, he experienced a grand mal seizure. Patient currently has short term memory loss and cannot answer questions about before Friday evening, 1/15 (this information is from text messages to his mother).
Age: 81.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Abasia, Arthralgia, Chest X-ray abnormal, Dysphagia, Fatigue
Clinical narrative: 1/8/10 progressive paralysis of extremities X 4. pins and needles in hands, which moved to elbows. and joint pain. then unable to swallow. also had blurry vision, severe fatigue. weakness in legs severe, unable to walk.  unable to hold head up in sitting position.
Age: 81.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Lumbar puncture normal, Muscular weakness, Paraesthesia, Paralysis, Posture abnormal
Clinical narrative: 1/8/10 progressive paralysis of extremities X 4. pins and needles in hands, which moved to elbows. and joint pain. then unable to swallow. also had blurry vision, severe fatigue. weakness in legs severe, unable to walk.  unable to hold head up in sitting position.
Age: 81.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Vision blurred
Clinical narrative: 1/8/10 progressive paralysis of extremities X 4. pins and needles in hands, which moved to elbows. and joint pain. then unable to swallow. also had blurry vision, severe fatigue. weakness in legs severe, unable to walk.  unable to hold head up in sitting position.
Age: 42.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Blood pressure increased, Dyspnoea, Electrocardiogram abnormal, Heart rate increased, Ventricular extrasystoles
Clinical narrative: Fast heart beat, premature ventricular contractions, difficulty breathing, elevated blood pressure
Age: 49.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Pruritus, Urticaria
Clinical narrative: Broke out in Hives from head to toe, itching, took Benadryl: 50mg every 6 hours.  This provided some relief.
Age: 89.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Dizziness, Flushing, Heart rate increased, Palpitations
Clinical narrative: Shortly after giving the patient the H1N1 vaccine, she began c/o rapid HR, dizziness, and flushing. She did not have any SOB, hives, or swelling. I let her sit for 15 min and her HR decreased from 100 to the 80s. She still felt dizzy and palpitations after sitting for 45 min. Because she wasn't feeling better, I called EMS and she was taken to the ER for further evaluation.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Dizziness, Hypoaesthesia, Rash
Clinical narrative: PT HAD RASHES ON THE FACE, NUMBNESS ON THE RIGHT ARM, DIZZINESS. EPINEPHRINE WAS ADMINISTERED 0.25 CC. IM
Age: 71.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Blood test, Nodule, Swelling face, Urticaria, X-ray
Clinical narrative: Initially presented as swelling of the face and jaw and hoarseness.  Later we realized she also had hives.  She was treated at a hospital emergency room, but symptoms did not improve much so she went to her primary care physician on 1/18.  She was given a prescription for steroids at that visit, and on 1/20 symptoms are beginning to improve though still present. On 1/19 she noticed a knot near her throat and has seen a doctor for that as well.  We are still what it is or whether it is related to the vaccine.
Age: 2.0
Sex: F
Vaccine: FLU(H1N1), HIBV
Symptoms: Erythema
Clinical narrative: 2CM red area
Age: 48.0
Sex: M
Vaccine: ANTH, FLUN3, HEP, TYP
Symptoms: Arthralgia, Immediate post-injection reaction, Myalgia
Clinical narrative: The exact time of the administration is actually unknown, however the computer system would not let me go on without entering something in that field.  Likewise the exact date and time of the onset of adverse symptoms in not known.  The patient only told me that the symptoms began "right after I got the immunizations".  It is worth noting that the Anthrax was the 6th in the series for this individual.  The adverse reaction is subjective, diffuse arthralgias and myalgias.
Age: 11.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Decreased appetite, Lethargy, Malaise, Oropharyngeal pain, Pyrexia
Clinical narrative: Started having fever at 7:00 p.m. (100 degrees). At 3:00 a.m. was 101 degress.  At 8:30 a.m. 101 degress.  Saw doctor at 9:00 a.m.  Checked for strep throat because he said his throat was hurting "bad".  Swab for strep was negative.  Lethargic.  Will eat but appetite is not normal.  Fever all day.  Treated with Tylenol.  Still not feeling well.
Age: 11.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Streptococcal identification test negative
Clinical narrative: Started having fever at 7:00 p.m. (100 degrees). At 3:00 a.m. was 101 degress.  At 8:30 a.m. 101 degress.  Saw doctor at 9:00 a.m.  Checked for strep throat because he said his throat was hurting "bad".  Swab for strep was negative.  Lethargic.  Will eat but appetite is not normal.  Fever all day.  Treated with Tylenol.  Still not feeling well.
Age: 0.49
Sex: M
Vaccine: DTAPIPVHIB, PNC, RV5
Symptoms: Angioedema, Eye swelling, Rash macular
Clinical narrative: Periorbital swelling and blotchy rash on his face.  No treatment given, was seen in the office at 1600 and the periorbital swelling had decreased but was still present.  Diagnosed with mild angioedema.
Age: 26.0
Sex: M
Vaccine: FLUN(H1N1), HEP, MNQ
Symptoms: Chest pain, Dizziness, Dyspnoea, Electrocardiogram
Clinical narrative: PT COMPLAINT OF CHEST PAIN, DIFFICULTY TO BREATH AND DIZZINESS
Age: 1.01
Sex: M
Vaccine: FLU(H1N1), MMR, PNC, VARCEL
Symptoms: Pyrexia
Clinical narrative: Fever to 101-102, lasted 5 days.  No other symptoms present.  Only given Tylenol.
Age: 53.0
Sex: F
Vaccine: FLUX(H1N1)
Symptoms: Arthralgia, Erythema, Joint swelling, Pain in extremity, Rash
Clinical narrative: 01/17/2010 7:30 AM Rash on face. Dimished after 8 hours. 01/17/2010 7:00 PM Joint pain in wrist. Dimished after 8 hours. 01/19/2010 9:00 PM Swollen, painful with redness in joint in toe of left foot.  Diminished after 8 hours.
Age: 41.0
Sex: F
Vaccine: MMR, PPV
Symptoms: Body temperature increased, Injection site cellulitis, White blood cell count increased
Clinical narrative: Cellulitis at injection site. Later spreading to entire upper arm over the next two days.
Age: 1.26
Sex: F
Vaccine: HEPA
Symptoms: Dyspnoea, Lethargy, Pyrexia, Rash
Clinical narrative: Lethargic, 102.2 fever, rash on chest/abdomen/back, heavy breathing
Age: 1.01
Sex: F
Vaccine: VARCEL
Symptoms: Tongue disorder, X-ray
Clinical narrative: Tongue became rigid and stiff, so hung out of mouth for periods of 20 minutes to 1 1/2 hours 4 times over the course of a week.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: ROUND SMALL PATCH OF HIVES AT LEFT STOMACH AREA, WENT AWAY WITH BENADRYL
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Convulsion, Electroencephalogram abnormal, Laboratory test normal, Nuclear magnetic resonance imaging normal
Clinical narrative: Generalized seizure -  neurologist consulted - MRI WNL, EEG with generalized spike waves, and placed on Lamictal.
Age: 49.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Asthenia, Blood product transfusion, Dizziness, Fatigue, Guillain-Barre syndrome
Clinical narrative: Symptoms: paresthesia, numbness, muscle pain, dizziness, weakness, fatigue. Admitted to Hospital on 12/11/2009 with working diagnosis of "transverse myelitis", discharged on 12/12/2009. Admitted to Medical Center on 12/15/09 with sensory-type Guillan-Barre/small fiber neuropathy, treated with IVIG and gabapentin.  Discharged 12/18/09.  Symptoms improved but still present as of today, 01/20/2010.
Age: 49.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Hypoaesthesia, Laboratory test, Myalgia, Myelitis transverse, Neuropathy peripheral
Clinical narrative: Symptoms: paresthesia, numbness, muscle pain, dizziness, weakness, fatigue. Admitted to Hospital on 12/11/2009 with working diagnosis of "transverse myelitis", discharged on 12/12/2009. Admitted to Medical Center on 12/15/09 with sensory-type Guillan-Barre/small fiber neuropathy, treated with IVIG and gabapentin.  Discharged 12/18/09.  Symptoms improved but still present as of today, 01/20/2010.
Age: 49.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Nuclear magnetic resonance imaging, Paraesthesia
Clinical narrative: Symptoms: paresthesia, numbness, muscle pain, dizziness, weakness, fatigue. Admitted to Hospital on 12/11/2009 with working diagnosis of "transverse myelitis", discharged on 12/12/2009. Admitted to Medical Center on 12/15/09 with sensory-type Guillan-Barre/small fiber neuropathy, treated with IVIG and gabapentin.  Discharged 12/18/09.  Symptoms improved but still present as of today, 01/20/2010.
Age: 0.35
Sex: M
Vaccine: DPP, OPV, PPV, TD
Symptoms: Dysphonia, Wheezing
Clinical narrative: Hoarseness and some wheezing about two hours after vaccinations.
Age: 11.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Asthenia, Dizziness, Dyspnoea, Migraine, Nausea
Clinical narrative: Pale, whole body weakness, light headed, difficulty breathing, shakey, nauseous, migraine, vomited once, fast breathing all lasting 30 mins. Dr. called, all vitals taken, all normal. Given Tylenol and Pepto Bismol. Now 10:45 PM and still has migraine and weakness and very pale. Pulse 72, b/p 107/68, Resp. 22. Monitoring at home for now.
Age: 11.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Pallor, Respiratory rate increased, Tremor, Vomiting
Clinical narrative: Pale, whole body weakness, light headed, difficulty breathing, shakey, nauseous, migraine, vomited once, fast breathing all lasting 30 mins. Dr. called, all vitals taken, all normal. Given Tylenol and Pepto Bismol. Now 10:45 PM and still has migraine and weakness and very pale. Pulse 72, b/p 107/68, Resp. 22. Monitoring at home for now.
Age: 41.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Headache, Hyperhidrosis, Nausea, Pain, Vomiting
Clinical narrative: Within 45mins pt felt sweaty, had a HA, felt nauseated and felt body aches. Pt vomited x 2 within an hour. Pt presented to medical. Vitals were stable. Pt was given 1L NSS and anti emetic. Pt was discharged home for the day.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Electromyogram, Guillain-Barre syndrome, Lumbar puncture
Clinical narrative: Admitted 12-19JAN10 at hospital for evaluation treatment of Guillain Barre syndrome.
Age: 67.0
Sex: F
Vaccine: TD
Symptoms: Local reaction, Pain, Pain in extremity
Clinical narrative: Local reaction, left arm pain, pt felt achy. Vaccine given on 1/7/10-symptoms started on 1/13/10. Amoxicillin 875 mg BID x 10 days.
Age: 56.0
Sex: F
Vaccine: FLU3, FLU(H1N1)
Symptoms: Injection site pain
Clinical narrative: Muscle pain at injection site continuing since vaccination date thru present.
Age: 56.0
Sex: F
Vaccine: FLU3, FLU(H1N1)
Symptoms: Injection site mass, Injection site pain
Clinical narrative: Muscle pain at injection site continuing since vaccination date thru present.
Age: 53.0
Sex: F
Vaccine: MEN
Symptoms: Paraesthesia
Clinical narrative: Paraesthesia
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, ANTH, SMALL
Symptoms: Blood creatine phosphokinase decreased, C-reactive protein increased, Chest pain, Myocarditis, Myoglobin blood increased
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 348416. A 22 year old male patient received the following vaccines on 14 May 2009: a percutaneous injection of ACAM2000 (lot number VV04003A); an intramuscular injection of TYPHIM VI (lot number B04242); and anthrax vaccine (Emergent Biosolutions, lot number FAV164). Sites of administration were not reported. Eleven days after vaccination, the patient developed sharp chest pain and was reportedly admitted to a medical center for myocarditis. According to hospital outpatient records, the patient was hospitalized for pericarditis. The patient was also seen for follow-up of the inpatient admission. The patient's medications include ranitidine and ibuprofen. On 25 May 2009 at 2:11 p.m., the following tests were performed: Troponin I Cardiac 3.31 (H*) ng/mL; Creatine Kinase MB 29.40 ng/mL; and Myoglobin 109.3 ng/mL. On 25 May 2009 at 3:40 p.m. the patient's C-Reactive Protein High Sensitivity was 107.27 and at 4:05 p.m. the patient's Troponin I Cardiac was 4.88 (H*) ng/mL. No additional information was provided. List of documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, ANTH, SMALL
Symptoms: Pericarditis, Troponin I increased
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 348416. A 22 year old male patient received the following vaccines on 14 May 2009: a percutaneous injection of ACAM2000 (lot number VV04003A); an intramuscular injection of TYPHIM VI (lot number B04242); and anthrax vaccine (Emergent Biosolutions, lot number FAV164). Sites of administration were not reported. Eleven days after vaccination, the patient developed sharp chest pain and was reportedly admitted to a medical center for myocarditis. According to hospital outpatient records, the patient was hospitalized for pericarditis. The patient was also seen for follow-up of the inpatient admission. The patient's medications include ranitidine and ibuprofen. On 25 May 2009 at 2:11 p.m., the following tests were performed: Troponin I Cardiac 3.31 (H*) ng/mL; Creatine Kinase MB 29.40 ng/mL; and Myoglobin 109.3 ng/mL. On 25 May 2009 at 3:40 p.m. the patient's C-Reactive Protein High Sensitivity was 107.27 and at 4:05 p.m. the patient's Troponin I Cardiac was 4.88 (H*) ng/mL. No additional information was provided. List of documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, ANTH, SMALL
Symptoms: Myocarditis, Pericardial disease, Troponin I increased
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 348416. A 22 year old male patient received the following vaccines on 14 May 2009: a percutaneous injection of ACAM2000 (lot number VV04003A); an intramuscular injection of TYPHIM VI (lot number B04242); and anthrax vaccine (Emergent Biosolutions, lot number FAV164). Sites of administration were not reported. Eleven days after vaccination, the patient developed sharp chest pain and was reportedly admitted to a medical center for myocarditis. According to hospital outpatient records, the patient was hospitalized for pericarditis. The patient was also seen for follow-up of the inpatient admission. The patient's medications include ranitidine and ibuprofen. On 25 May 2009 at 2:11 p.m., the following tests were performed: Troponin I Cardiac 3.31 (H*) ng/mL; Creatine Kinase MB 29.40 ng/mL; and Myoglobin 109.3 ng/mL. On 25 May 2009 at 3:40 p.m. the patient's C-Reactive Protein High Sensitivity was 107.27 and at 4:05 p.m. the patient's Troponin I Cardiac was 4.88 (H*) ng/mL. No additional information was provided. List of documents held by sender: none.
Age: 39.0
Sex: M
Vaccine: SMALL
Symptoms: Erythema, Inflammation, Injection site streaking, Lymphadenopathy, Nausea
Clinical narrative: This case was received on 02 September 2009 via a QScan on the VAERS database, under reference number 348960. A 39 year old male patient received the following vaccination on 24 May 2009: smallpox lot number VV04-003-A. Ten days after vaccination the patient reported a three day history of fever to 101 degrees Fahrenheit, nausea, marked inflammation of his shoulder with bilateral swelling of axillary and cervical lymph nodes and red streaking around shoulder. The patient responded in a day or two to treatment with MOTRIN 400 milligrams, BENADRYL 25 milligrams, KEFLEX 500 milligrams three times per day for ten days and CIPROFLOXACIN 500 milligrams twice per day for ten days. The patient recovered. No additional information was provided. List of Documents held by Sender: None
Age: 39.0
Sex: M
Vaccine: SMALL
Symptoms: Pyrexia
Clinical narrative: This case was received on 02 September 2009 via a QScan on the VAERS database, under reference number 348960. A 39 year old male patient received the following vaccination on 24 May 2009: smallpox lot number VV04-003-A. Ten days after vaccination the patient reported a three day history of fever to 101 degrees Fahrenheit, nausea, marked inflammation of his shoulder with bilateral swelling of axillary and cervical lymph nodes and red streaking around shoulder. The patient responded in a day or two to treatment with MOTRIN 400 milligrams, BENADRYL 25 milligrams, KEFLEX 500 milligrams three times per day for ten days and CIPROFLOXACIN 500 milligrams twice per day for ten days. The patient recovered. No additional information was provided. List of Documents held by Sender: None
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Cellulitis, Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database. A 26 year old male patient received the following vaccines on 02 June 2009: a percutaneous injection of VACCINIA, ACAM2000, lot number VV04003A; an intramuscular injection of BIOTHRAX, Emergent Biosolutions, lot number FAV177 and an intramuscular injection of BOOSTRIX, GlaxoSmithKline, lot number C2936BA. The sites of administration were not reported. Seven days after vaccination the patient developed local cellulitis. There was redness, induration, pain, itching and warmth in an area 14 cm x 11.5 cm surrounding the vaccination site. No treatment was reported. The patient recovered. List of documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Injection site warmth
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database. A 26 year old male patient received the following vaccines on 02 June 2009: a percutaneous injection of VACCINIA, ACAM2000, lot number VV04003A; an intramuscular injection of BIOTHRAX, Emergent Biosolutions, lot number FAV177 and an intramuscular injection of BOOSTRIX, GlaxoSmithKline, lot number C2936BA. The sites of administration were not reported. Seven days after vaccination the patient developed local cellulitis. There was redness, induration, pain, itching and warmth in an area 14 cm x 11.5 cm surrounding the vaccination site. No treatment was reported. The patient recovered. List of documents held by sender: none.
Age: 19.0
Sex: F
Vaccine: ANTH, SMALL, TYP
Symptoms: Erythema, Nodule, Rash
Clinical narrative: This case was received on 02 September 2009 via QScan search on the VAERS database. A 19 year old female patient received the following vaccines on 20 May 2009: a percutaneous injection of VACCINIA (ACAM2000, lot number VV04003A); TYPHIM VI, lot number B0706; and BIOTHRAX, Emergent Biosolutions, lot number SAV177. Fourteen days after vaccination the patient developed a bilateral finger rash and well demarcated, erytherations modules. No additional information was provided. List of documents held by sender: none.
Age: 25.0
Sex: F
Vaccine: SMALL
Symptoms: Lymphadenitis
Clinical narrative: A 25 year old female patient received a percutaneous injection in the left deltoid of ACAM2000 (Lot number VV04-003A) on 01 June 2009. Four days after vaccination the patient developed acute post-vaccinal lymphadenitis involving the left axillary, supraventricular and cervical nodes. It was non-suppurative and there were no other systemic symptoms. No additional information was provided. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination and the lot number has been verified as an ACAM2000 lot number. List of documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: HEPAB, SMALL, TYP
Symptoms: Blood creatine phosphokinase normal, Chest pain, Headache, Pyrexia, Troponin
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 349449. A 20 year old male patient received the following vaccines on 28 May 2009: a percuotaneous injection of ACAM2000 (lot number W04003A); an intramuscular injection of TYPHIM VI (lot number B0347); and TWINRIX (GlaxoSmithKline, lot number AHABB100AA). The sites of administration were not reported. Eight days after vaccination the patient developed chest pain, headache and fever. Troponin and creatine phosphokinase blood levels were reported as negative. The patient recovered. List of documents held by sender: none
Age: 38.0
Sex: M
Vaccine: SMALL
Symptoms: Discomfort, Lymphadenopathy, Pyrexia
Clinical narrative: This case was received on 02 September 2009 via QScan search on the VAERS database, under reference number 349488. A 38 year old male patient received a percutaneous injections of smallpox vaccine live (ACAM2000, lot number VVW4-003A) on 07 June 2009. Ten days after vaccination, the patient reported a fever of up to 101 degrees farenheit. The patient also complained of discomfort under the arms from swollen lymph nodes and discomfort in the xyphoid process, under the left rib cage. The patient described it as feeling "like it was pushing out". The patient was instructed to take MOTRIN and seek care in the emergency room if symptoms worsened.  The patient recovered,
Age: 19.0
Sex: M
Vaccine: SMALL
Symptoms: Pruritus, Skin lesion
Clinical narrative: This case was received on 02 September 2008 via a QScan search on the VAERS database, under reference number 349675. A 19 year old male patient received the following vaccination on 12 June 2009: smallpox (lot number VV04-003A). Eight days post vaccination the patient complained of lesions on right wrist, hard and genital region. He was instructed on good handing washing technique and to keep the lesions covered. He was prescribed Atarax for the itching. The outcome of the patient was not reported. No additional information was reported. List of Documents held by Sender: None.
Age: 38.0
Sex: M
Vaccine: SMALL
Symptoms: Pruritus generalised
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 349858. A 38 year old male patient received a percutaneous injection of smallpox vaccine (ACAM2000, lot number VV04003A)  on 22 June 2009. On the same day as vaccination, the patient developed severe itching from head to toe. The patient was treated with BENADRYL and CLARITIN. The patient recovered. This case is 1 of 8 cases reported to VAERS on 23 June 2009 that have been the same suspect product, date of administration, event, narrative and treatment. There were two lot numbers reported in these cases. Six cases had a reported lot number of VV04003A and two cases had a reported lot number of VV040034. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.
Age: 19.0
Sex: M
Vaccine: SMALL
Symptoms: Pruritus generalised
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 349859. A 19 year old male patient received a percutaneous injection of smallpox vaccine (ACAM200, lot number VV04003A) on 22 June 2009. On the same day as vaccination, the patient developed severe itching from head to toe. The patient was treated with BENADRYL and CLARITIN. The patient recovered. This case is 1 of 8 cases reported to VAERS on 23 June 2009 that have the same suspect product, date of administration, event, narrative treatment. There were two lot numbers reported in these cases. Six cases had reported a lot number of VV04003A and two cases had reported lot number of VV040034. The corresponding ARISg numbers for the other 7 case in this group are: 2009-03757; 2009-03759; 2009-03760; 2009-03761; 2009-03762; 2009-03763; and 2009-03764.   NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.   List of documents held by the sender: none.
Age: 22.0
Sex: M
Vaccine: SMALL
Symptoms: Pruritus generalised
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 349860. A 22 year old male patient received a percutaneous injection of smallpox (vaccina) vaccine (ACAM2000, lot number VV04003A) on 22 June 2009. On the same day as vaccination, the patient developed severe itching from head to toe. The patient was treated with BENADRYL and CLARITIN. The patient recovered. This case is 1 of 8 cases reported to VAERS on 23 June 2009 that have the same suspect product, date of administration, event, narrative and treatment. There were two lot numbers reported in these cases. Six cases had a reported lot number of VV04003A and two cases had a reported lot number of VV040034. The corresponding ARISg numbers for the other 7 cases in this group are: 2009-03757; 2009-03758; 2009-03760; 2009-03761; 2009-03762; 2009-03763; and 2009-03764. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 39.0
Sex: M
Vaccine: SMALL
Symptoms: Pruritus generalised
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 349861. A 39 year old male patient received a percutaneous injection of ACAM2000 (Lot number VV04003A) on 22 June 2009. On the same day as vaccination, the patient developed severe itching from head to toe. The patient was treated with BENADRYL and CLARITIN. The patient recovered. This case is 1 of 8 cases reported to VAERS on 23 June 2009 that have the same suspect product, date of administration, event, narrative and treatment. There were two lot numbers reported in these cases. Six cases had a reported lot number of VV040C3A and two cases had a reported lot number of VV040034. The corresponding ARISg numbers for the other 7 cases in this group are: 2009-03757; 2009-03758; 2009-03759; 2009-03761; 2009-03762; 2009-03763; and 2009-03764. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.
Age: 22.0
Sex: M
Vaccine: SMALL
Symptoms: Pruritus generalised
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 349862. A 22 year old male patient received a percutaneous injection of ACAM2000 (lot number VV04003A) on 22 June 2009. On the same day as vaccination, the patient developed severe itching from head to toe. The patient was treated with BENADRYL and CLARITIN. The patient recovered. This case is 1 of 8 cases reported to VAERS on 23 June 2009 that have the same suspect product, date of administration, event, narrative and treatment. There were two lot numbers reported in these cases. Six cases had a reported lot number of VV04003A and two cases had a reported lot number of V040034. The corresponding ARISg numbers for the other 7 cases in this group are: 2009-03757; 2009-03758; 2009-03759; 2009-03760; 2009-03762; 2009-03763; 2009-03764. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none
Age: 23.0
Sex: F
Vaccine: SMALL
Symptoms: Pruritus generalised
Clinical narrative: A 23 year old female patient received a percutaneous injection of smallpox vaccine (ACAM2000, lot number VV040034) on 22 June 2009. On the same day as vaccination, the patient developed severe itching from head to toe. The patient was treated with BENADRYL and CLARITIN. The patient recovered. This case is 1 of 8 cases reported to VAERS on 23 June 2009 that have the same suspect product, date of administration, event , narrative and treatment. There were two lot numbers reported in these cases. Six cases had a reported lot number of VV04003A and two cases had a reported lot number of VV040034. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Pruritus generalised
Clinical narrative: This case was received on 02 September 2009 via a QScan search of the VAERS database, under reference number 349864. A 24 year old male patient received a percutaneous injection of smallpox vaccine (ACAM2000, lot number VV040034) on 22 June 2009. On the same day as vaccination, the patient developed severe itching from head to toe. The patient was treated with BENADRYL and CLARITIN. The patient recovered. This case is 1 of 8 cases reported to VAERS on 23 June 2009 that have the same suspect product, date of administration, event, narrative and treatment. There were two lot numbers reported in these case. Six cases had a reported lit number of VV04003A and two cases had a reported lot number of VV040034. The corresponding ARISg numbers for the other 7 case in this group are: 2009-03757; 2009-03758; 2009-03759; 2009-03760; 2009-03761; 2009-03762; and 2009-03764.  NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.   List of documents held by sender: none.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Pruritus generalised
Clinical narrative: A 24 year old male patient received a percutaneous injection of SMALLPOX vaccine (ACAM2000, lot number VV04003A) on 22 JUNE 2009. On the same day as vaccination, the patient developed severe itching from head to toe. The patient was treated with Benadryl and Claritin. The patient recovered. This case is 1 of 8 cases reported to VAERS on 23 June 2009 that have the same suspect product, date of administration, event, narrative and treatment. There were two lot numbers reported in these cases. Six cases had reported a lot number of VV04C03A and two cases had reported lot number of VV040034. The corresponding ARISg numbers for the other / cases in this report are: 2009-03757; 2009-03758; 2009-03759; 2009-03760; 2009-03761; 2009-03762 and 2009-03763. Note: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed SMALLPOX vaccine at the time of the patients vaccination. List of documents held by sender: none
Age: 39.0
Sex: F
Vaccine: SMALL
Symptoms: Biopsy skin, Erythema, Nausea, Pruritus, Rash papular
Clinical narrative: This case was received on 02 September 2009 via a QScan on the VAERS database, under reference number 350008. A 39 year old female patient received a percutaneous injection of ACAM2000, lot number VV04-003A) on 12 June 2009. A normal take was documented on 18 June 2009 and no adverse side effects were noted. Ten days after vaccination, the patient developed vaccinia from vaccination. She presented with red papules and small white pustules on both arms, inner thighs and upper chest. The patient also had a sunburn on both arms. No headache, fever, malaise, or vomiting were reported. The patient reported mild nausea the day prior. A robust take was noted at the vaccination site with some satellite lesions at the vaccination site and on both arms. The patient was prescribed Benadryl by mouth. Later the same day, the patient reported that the rash was increasing and spreading to the upper chest, upper back and abdomen. On Day 11 the patient was seen by Dermatology and prescribed Claritin. The patient was also seen by her primary care physician and prescribed ZYRTEC. The patient was told to stay home for one week. By Day 12, the patient reported no new lesions were appearing and the redness and itching were decreasing. Medical records indicated that a biopsy of the satellite lesions was performed on Day 13 however no results were reported. The following test results were performed in 2008 and  retrieved from medical records: Hepatitis B Surface Antibody, reactive; Mumps Virus Antibody, positive; Measles Antibody, positive; Rubella Antibody, positive; and Varicella Zoster Virus IGG, positive. No additional information was provided. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination and the lot number has been verified as an ACAM2000 lot number. Relevant Test/Laboratory Data  : Medical records indicated that a biopsy of the satellite lesions was performed on Day 13 however no results were reported.
Age: 39.0
Sex: F
Vaccine: SMALL
Symptoms: Rash pustular, Robust take following exposure to vaccinia virus, Sunburn, Vaccination complication, Vaccinia virus infection
Clinical narrative: This case was received on 02 September 2009 via a QScan on the VAERS database, under reference number 350008. A 39 year old female patient received a percutaneous injection of ACAM2000, lot number VV04-003A) on 12 June 2009. A normal take was documented on 18 June 2009 and no adverse side effects were noted. Ten days after vaccination, the patient developed vaccinia from vaccination. She presented with red papules and small white pustules on both arms, inner thighs and upper chest. The patient also had a sunburn on both arms. No headache, fever, malaise, or vomiting were reported. The patient reported mild nausea the day prior. A robust take was noted at the vaccination site with some satellite lesions at the vaccination site and on both arms. The patient was prescribed Benadryl by mouth. Later the same day, the patient reported that the rash was increasing and spreading to the upper chest, upper back and abdomen. On Day 11 the patient was seen by Dermatology and prescribed Claritin. The patient was also seen by her primary care physician and prescribed ZYRTEC. The patient was told to stay home for one week. By Day 12, the patient reported no new lesions were appearing and the redness and itching were decreasing. Medical records indicated that a biopsy of the satellite lesions was performed on Day 13 however no results were reported. The following test results were performed in 2008 and  retrieved from medical records: Hepatitis B Surface Antibody, reactive; Mumps Virus Antibody, positive; Measles Antibody, positive; Rubella Antibody, positive; and Varicella Zoster Virus IGG, positive. No additional information was provided. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination and the lot number has been verified as an ACAM2000 lot number. Relevant Test/Laboratory Data  : Medical records indicated that a biopsy of the satellite lesions was performed on Day 13 however no results were reported.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Arthralgia, Blister, Blood culture negative, Blood lactate dehydrogenase normal, Body temperature increased
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.
Age: 34.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: C-reactive protein increased, Cellulitis, Chills, Coagulation test normal, Culture urine negative
Clinical narrative: This case was received on 02 September 2009 via a QScan search on the VAERS database, under reference number 350022. A 34 year old male patient received a percutaneous injection in the left deltoid of SMALLPOX vaccine, (ACAM2000, lot number VV04003A) on 29 April 2009. The patient received the following vaccines 6 days earlier on 23 April 2009: dose 1 of ANTHRAX, dose 1 on HEP B, INFLUENZA (intramuscular) and TYPHOID. The manufacturer, lot number and site of administration were not reported. The patient was admitted to the hospital on 13 May 2009 with presumptive disseminated vaccinia and right knee cellulitis. Approximately 12 days after receiving SMALLPOX, the patient developed fever, chills, malaise, loss of appetite, headache, sore throat, productive cough and mild shortness of breath. The patient was initially seen on Day 12 (11 May 2009) for upper respiratory illness (URI) - type symptoms. The patient reported a 3 week history of intermittent chest congestion. He was diagnosed with pharyngitis and prescribed Z-pack, ZYRTEC and MUCINEX-D. That night, the patient noted pain and swelling at the SMALLPOX vaccination site and an increase in temperature (not measured). He was seen in the Emergency Room and diagnosed with left arm cellulitis. The patient was prescribed SEPTRA and CLINDAMYCIN. The patient was seen at a medical center for follow-up on 12 May 2009. He had a fever of 101.7 Farenheit. He also had a small tender pustule in right axilla and right knee pain and swelling. By 13 May 2009, the patient developed scattered pustular lesions over the scalp, right hip, and left leg. He also had increased right knee pain and swelling. He was admitted to hospital with a presumptive diagnoses of right knee cellulitis and disseminated vaccinia. An initial assessment by Infectious Disease performed on 14 May 2009 indicated: overall clinical improvement, but continued right knee swelling and warmth without tenderness; blanchable red rash at smallpox vaccine injection site (stable pustule), and over right knee; multiple scattered tense blisters, not excluding palms and soles: vesicles in various stages, characterized as yellow on erythematous base, umbilicated or ruptured, some becoming pustular, some with honey-colored crusts; distributed over scalp, neck, shoulders axillae, upper extremities, trunk, buttocks, lower extremities. Laboratory tests performed between 13 May 2009 and 15 May 2009 include: ESR 66-75 (high); CRP 10-12 (high); WBC 3000 range (low); Hematocrit 31-32 (low); Platelet 65-74 (low); normal chemistries, liver panel, LDH, ferritin, retic count, coagulation tests, and urinalysis; negative wound, blood and urine cultures. The patient recovered. There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. List of documents held by sender: none.